Original Research
Published on 19 Jul 2021
Tirbanibulin Attenuates Pulmonary Fibrosis by Modulating Src/STAT3 Signaling
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.693906
- 3,640 views
- 13 citations
Type at least 3 characters
580 articles
Articles
Original Research
Published on 15 Jul 2021
Naringin Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension Through Endothelial-To-Mesenchymal Transition Inhibition
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.696135
- 4,466 views
- 12 citations
Original Research
Published on 15 Jul 2021
Poloxamer 188 Attenuates Ischemia-Reperfusion-Induced Lung Injury by Maintaining Cell Membrane Integrity and Inhibiting Multiple Signaling Pathways
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.650573
- 4,031 views
- 11 citations
Original Research
Published on 08 Jul 2021
Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite–Induced Allergic Rhinitis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.681724
- 2,779 views
- 9 citations
Review
Published on 08 Jul 2021
In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.671589
- 14,500 views
- 25 citations
Original Research
Published on 07 Jul 2021
Phenylethanoid Glycosides From Callicarpa kwangtungensis Chun Attenuate TNF-α-Induced Cell Damage by Inhibiting NF-κB Pathway and Enhancing Nrf2 Pathway in A549 Cells
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.693983
- 3,732 views
- 17 citations
Review
Published on 05 Jul 2021
Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.692551
- 9,875 views
- 22 citations
Original Research
Published on 05 Jul 2021
The Specific Connexin 43–Inhibiting Peptide Gap26 Improved Alveolar Development of Neonatal Rats With Hyperoxia Exposure
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.587267
- 2,773 views
- 5 citations
Original Research
Published on 29 Jun 2021
Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.704316
- 8,662 views
- 12 citations
Review
Published on 29 Jun 2021
Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.691621
- 9,116 views
- 27 citations
Review
Published on 29 Jun 2021
The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.698905
- 23,649 views
- 43 citations
Original Research
Published on 28 Jun 2021
Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.668825
- 6,222 views
- 15 citations
Original Research
Published on 23 Jun 2021
Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.690407
- 3,562 views
- 21 citations
Original Research
Published on 23 Jun 2021
Allergic Asthma-Induced Cognitive Impairment is Alleviated by Dexamethasone
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.680815
- 13,028 views
- 22 citations
Original Research
Published on 18 Jun 2021
Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.693061
- 4,083 views
- 13 citations
Original Research
Published on 17 Jun 2021
Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.669642
- 8,806 views
- 71 citations